• dannick
    Is anyone still tracking $BCLI ? It seems to have had no commentary for the best part of a year even though a lot has changed.
    Reply (5)
    • nsahbti: $BCLI is under the radar, soon will grab notice with new data. in line for govt. grant like $PSTI got
    • Tile: I loaded up 3 weeks ago. They are waiting on the FDA to start a phase 2 trial in ALS here in the US. They have Orphan status for NurOwn.
    • dannick: I have a small position but am cautious of adding more as other companies in the ALS space are further along.
    • Tile: Competitor is $CUR who is also running a phase 2 study. ALS is an unmet medical need. I hold 30k shares. Do your dd before investing more.
    • dannick: CUR and $STEM . I own CUR (2250 shares) but not STEM. Might buy it if it drops purely on the basis of what goes down
      From other sites